Trial intelligence / Profile preview

Exploratory pharmacokinetic study of glycyrrhetinic acid during Yokukansan administration in healthy Japanese adults

jRCTs061210011Recruiting

Sponsor
Tsumura & Co.
Start
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of yokukansan, sponsored by Tsumura & Co. Primary endpoint: Primary: correlation between fecal glycyrrhizin bioactivity and serum glycyrrhetinic acid pharmacokinetics. Started Oct 2022; status: recruiting.

02

Drugs

yokukansan

Beyond the preview

Go deeper on jRCTs061210011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs061210011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call